Navigation Links
Electrode Placement Key to Brain Stimulation for Parkinson's Patients
Date:5/12/2008

Re-implantation of devices at shorter distances improved motor scores, researchers find

MONDAY, May 12 (HealthDay News) -- A few millimeters can make a huge difference for Parkinson's patients treated with electrodes surgically implanted in the brain, a new study finds.

Implanting electrodes to stimulate the subthalamic nucleus, a part of the brain potentially related to impulsivity, has helped people with Parkinson's disease reduce their medication intake by up to 65 percent and lessen characteristic motor impairment by as much as 70 percent, according to background information for the study published in the May issue of Archives of Neurology.

But a study of seven Parkinson's patients who did not respond well to the procedure shows that additional surgery to correct the electrode placement greatly improved the patients' condition and dependence on medication.

"The principal cause of these poor results arises from imprecision of electrode placement, leading to non-stimulation of the target as required," the authors wrote. "Misplacement of the electrode by only a few millimeters may have occurred."

All but one of the patients who received the second surgery showed improvement afterward. When not on medication, their motor scores increased by 26.7 percent following the first surgery and 59.4 percent after the second. Their dose of levodopa, a Parkinson's medication, dropped by more than half from 1,202 milligrams to 534 milligrams.

The average distance between the electrodes and the target point of stimulation -- which was determined by evaluating electrode placement in patients whose surgery was successful the first time -- decreased from 5.4 to 2 millimeters. The shorter the distance, the greater the patients' improvement in motor scores.

The patients had the re-implantation surgery 12 to 23 months after the original procedure. Motor scores and medication doses were assesse
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Speedy Procedures Demonstrate Excitement and Continued Interest in Novel Multi-Electrode Ablation System
2. Facet Solutions, Inc. Completes Combination Facet Joint and Disc Replacement Study
3. Patients receive heart valve replacements without surgery using high-tech device
4. Hormone Replacement May Cut Risk for Age-Linked Eye Disease
5. Study shows increase of hip and knee replacements in the US
6. New study finds adverse effects of estrogen replacement therapy are related to the dose
7. Derma Sciences Raises $6.1 Million Through Private Placement
8. Alert to Women: What Your Doctor Prescribed for Hormone Replacement May Be Killing You and Your Rights Are About to Be Taken Away
9. Researchers control growth rate of replacement blood vessels, tissues
10. Hormone replacement therapy appears to have no effect on risk and severity of rheumatoid arthritis
11. Lotus Pharmaceuticals Raises $5 Million in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Steven Mosher,...I), says that America has,a hidden problem of sex ...feminists refuse to address., In PRI,s latest You...,East and South Asian countries, of sex-selective ...actice has already claimed the lives of over 100,m...
(Date:7/24/2008)...July 24 /PRNewswire/ -- A new alliance of animal,l...roblems -- obesity -- in,pets and pet owners., Am...ne third of us are,obese, including 9 million chil...ok like us -- mirror us with similar health issues...partnership that includes,Harvard Medical Center, ...
(Date:7/24/2008)... CosmetaLife clinical trial results could lead ...cost-effective treatment for deep lines and wrinkl...inn. (PRWEB) July 24, 2008 -- Gel-Del Technologie...company announced that it has concluded clinical t...at company officials say holds potential to be a m...
(Date:7/24/2008)...RNewswire-FirstCall/ --, Key Highlights, Misys p...ns and is now,raising targets for the next phase o...) of GBP492m up 6%, bringing Group operating profi...xecuting on its strategy and entering,into the nex...m for growth., To view the Multimedia News Releas...
Breaking Medicine News(10 mins):Health News:PRI: Pro-Life Leader Blames Feminist Groups for Slaughter of Girls 2Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4
...tudy suggests that eating more fiber and fruit eac...he study is based on the results of examining the ...ht or obese adults. The study found that normal w...dietary fiber and 43 percent more complex carbohyd...
...n Saturday reported a new outbreak of bird flu amo... Xinjiang.// The national avian influenza laborat...he H5N1 avian influenza virus, stemming from an ou...4 near the town of Aksu, the agriculture ministry ...
...Food and Drug Administration (FDA) gave approval t...e matchstick sized contraceptive is implanted bene...regnancy for three year after which it may be repl...Implanon said that the implant would release a low...
... (tigecycline)is a new, expanded broad-spectrum IV...a wide range of infections including those caused ...llin-resistant Staphylococcus aureus (MRSA). It wi...y of this new antibiotic comes at a time when the ...
Other Medicine News:Health News:Broad Spectrum Antibiotic Available for Antibiotic Resistant Bacteria 2
(Date:7/22/2008)... the Importance to Patients of Passing a ...HMOND, Va., July 22 /- Insm... biologics and biopharmaceuticals, today,announced...resent at a,Congressional briefing on Friday, July...tablishing an approval pathway for follow-on,biolo...
(Date:7/22/2008)...y 22 /- NicOx S.A.,(Euronex...completed the,enrollment of 417 osteoarthritis (OA...nical pharmacology studies in the United States, i...trials are designed to assess the,blood pressure p...and,naproxen, using the Ambulatory Blood Pressure ...
(Date:7/21/2008)...-- The University of Oxford Clinical Trial,Service...osed that the,hypothesis-generating results of the...wing the combined cancer results from the SHARP an... the overall findings to,the relevant regulatory a...s., The two hypothesis-testing trials (SHARP and ...
(Date:7/21/2008)... clinicians identify risk in patients, includin...tin therapy, BIRMINGHAM, Ala., July 21 /PRNewswir...ch, researchers have identified a link between,adi...ation could help,physicians trying to pinpoint the...-lowering treatments in at-risk patients., The as...
Breaking Medicine Technology:Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 2Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 3VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 2VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 3Sex is thirst quenching for female beetles 165 1Sex is thirst quenching for female beetles 165 2Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns Australia 213 1Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns Australia 213 2KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates 210 1KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates 210 2Advanced Life Sciences Announces ALS 357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 149 1Advanced Life Sciences Announces ALS 357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 149 2Advanced Life Sciences Announces ALS 357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 149 3Advanced Life Sciences Announces ALS 357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 149 4
...imaging technique suggests how lithium works as a,...ientists at UCLA have shown,that lithium, long the...s the amount of gray matter in the brains of patie... in the July issue of the journal,Biological Psych...e Bearden, a clinical neuropsychologist and assist...
...May Provide Cancer Patients With Improved Potentia... 16, 2007 /PRNewswire/ -- Insert,Therapeutics, Inc...ch Corporation announced today its novel delivery ...poster presentation at,the 2007 American Associati...articular, this poster includes new research findi...
Other Medicine Technology:UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 2UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4
Operating Microscope with excellent maneuverability. Konan made it compact and light weight maintaining high quality. Easy switchover from straight to oblique by simply changing the adapter. Konan's
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure.
With side bite Instrument recommended to catch the polypropylene thread in the nose.
Instrument necessary for insertion of Ritleng Bicanaliculus systems and of Self-Threading Monoka systems.
Medicine Products: